Logan Circle's Viceroy Hotel Wants to Offload Its Marquee Restaurant
The days are numbered for the Viceroy Washington D.C.'s food and beverage outlets. The 3,750-square-foot restaurant space, petite rooftop pool bar, and lobby-level coffee shop are all up for grabs, per a newly posted call for bidders. Two years after opening, the posh, 178-room hotel off the buzzy 14th Street NW corridor unveiled its glamorous American restaurant Dovetail in 2022. A big Hollywood party for White House Correspondents' Dinner weekend christened the promising indoor-outdoor venue. Vet chef James Gee, who formerly led the kitchen at I'm Eddie Cano (Chevy Chase) and Cittanuova (East Hampton), sent out catch-all menus bursting with colorful produce, seafoods, and plump Roseda Farm burgers and steaks (1430 Rhode Island Avenue NW). Gee tells Eater he parted ways with the LA-based hospitality company last month. The incoming operator would also handle all catering capabilities for the boutique hotel. Italian spirits company announces first D.C. restaurant
The team behind Ivy City's popular amaro distiller Don Cicco & Figli opens Tarì Trattoria in the Union Market district next month (300 Morse Street NE). Founder Francesco Amodeo turns to his Amalfi Coast roots with whitebait fritters dipped in almond pesto, house-made rabbit pasta with thyme, and Campania's favorite dessert (eggplants, candied fruits, almonds, and chocolate). Seafood flown in from Italy, Japan, and beyond will be dry-aged on-site, and dishes are prepared with olive oil and sea salt in lieu of butter. Mixologist and Barmini alum Alex Pisi plans to make a spiked edition of Italy's rocketship popsicle on an edible licorice stick. The 32-seat dining room, framed with old photos of Amodeo's fisherman uncle at work, is joined by an even-bigger alfresco situation out front. Meet Frederick's new 7th sister
Downtown Frederick, Maryland's Ordinary Hen closed on Saturday, May 17, and the historic mansion site already has a new name and menu (228 North Market). Under the direction of chef Christian Blouin, formerly of Firestone's, and new ownership, 7th Sister plans to celebrate the mid-Atlantic legacy of the Houck sisters, who built the mansion in the heart of Frederick. Dishes include oysters dressed in blackberry mignonette and seared crab cakes flanked with whole grain mustard. Reservations go live on Thursday, May 29. Jake's Tavern grows up
Shaw's six-year-old neighborhood destination known for its drafts, burgers, wings, sports, and secret back patio outfitted with a boat is ready to expand up top. Per an announcement on social media, its long-awaited second floor with a TBA name plans to 'open soon' for private events, DJs, and game-day watch parties.
Sign up for our newsletter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
20 stocks primed for rapid growth while trading at half of Nvidia's valuation
When selecting investments, it is easy to get hung up on a particular metric, such as a dividend yield or a price ratio, but investors need to look deeper or they might miss opportunities. Inc. AMZN provides an example: Its stock has typically traded at a high price-to-earnings ratio. Investors tend to look at a stock's forward P/E ratio, which is the price divided by analysts' consensus estimate for earnings per share over the following 12 months. Over the past 10 years, Amazon's stock has traded at an average forward P/E of 79.5, while the S&P 500 SPX has traded at an average forward P/E of 18.7, according to FactSet. But Amazon's stock was up 855% for 10 years through Friday, while the S&P 500 returned 235% with dividends reinvested. My daughter's boyfriend, a guest in my home, offered to powerwash part of my house — then demanded money What on Earth is going on with the American consumer? My father-in-law has dementia and is moving in with us. Can we invoice him for a caregiver? 'The situation is extreme': I'm 65 and leaving my estate to only one grandchild. Can the others contest my will? 20 stocks primed for rapid growth while trading at half of Nvidia's valuation It turns out that for Amazon's management team, bottom-line earnings traditionally weren't a focus. The emphasis was on reinvesting most of the cash being generated to expand the business in multiple directions. So the Amazon story was about revenue growth, rather than EPS growth. And that brings us to Nvidia Corp. NVDA. Last week Laila Maidan looked into Nvidia's relatively high forward P/E and explained why the stock might still be considered a bargain for long-term investors, based on analysts' expectations for the company's revenue growth. Nvidia's stock traded at a forward P/E of 28.1 at Friday's close, while the S&P 500 traded at a weighted forward P/E of 21.4. It is not a surprise to see Nvidia trading at a P/E valuation that is 31% higher than that of the index. But based on consensus estimates among analysts polled by FactSet, Nvidia is expected to increase its sales per share at a compound annual growth rate of 41.7% through 2026, versus an expected sales-per-share CAGR of 5.5% for the S&P 500. All such estimates in this article are adjusted by FactSet to match calendar years; about 20% of companies in the S&P 500 have fiscal reporting periods that don't match the calendar. For Nvidia, investors pay a premium for the higher expected growth rate. And that sets the stage for a stock screen. Which companies trading at low P/E multiples are also expected to increase revenue quickly? For this screen we are looking at revenue growth projections — specifically sales per share. We are using the per-share numbers because they reflect expected dilution to a company's share count if it issues new shares to help fund an acquisition. Merging with a competitor will obviously make revenue increase. But if the share count rises significantly, sales per share will be lower. The per-share numbers help investors to understand whether or not a company might have overpaid for an acquisition. Starting with the S&P 500, we narrowed the list to companies trading at forward P/E ratios of 14 or less — half Nvidia's valuation. Actually, we rounded down, so the list was confined to stocks trading at a forward P/E of less than 14.5. Then we sorted the list by expected sales-per-share CAGR from calendar 2024 through 2026, based on consensus estimates among analysts polled by FactSet. Here are the 20 stocks in the S&P 500 with the highest expected sales-per-share CAGR through 2025 among those trading at a P/E of less than 14.5: Company Ticker Industry Forward P/E Expected sales-per-share CAGR from 2024 through 2026 Expand Energy Corp. EXE Integrated Oil 12.0 39.6% Super Micro Computer Inc. SMCI Computer Processing Hardware 14.1 31.9% EQT Corp. EQT Integrated Oil 13.6 26.0% Micron Technology Inc. MU Semiconductors 9.4 23.2% Coterra Energy Inc. CTRA Integrated Oil 8.3 21.2% First Solar Inc. FSLR Solar Power Equipment 8.7 20.5% Norwegian Cruise Line Holdings Ltd. NCLH Hotels/ Resorts/ Cruiselines 7.9 15.9% Incyte Corp. INCY Pharmaceuticals 10.7 15.5% Seagate Technology Holdings PLC STX Computer Peripherals 12.4 15.0% Gen Digital Inc. GEN Software 11.1 13.0% DaVita Inc. DVA Medical/ Nursing Services 11.6 12.0% Oneok Inc. OKE Oil & Gas Pipelines 14.2 11.8% Molina Healthcare Inc. MOH Managed Healthcare 11.7 11.8% Aptiv PLC APTV Electrical Products 9.0 10.9% UnitedHealth Group Inc. UNH Managed Healthcare 12.5 10.7% Elevance Health Inc. ELV Managed Healthcare 10.5 10.4% Dell Technologies Inc. Class C DELL Computer Processing Hardware 11.4 10.2% American International Group Inc. AIG Multi-Line Insurance 12.2 10.2% HCA Healthcare Inc. HCA Hospital/ Nursing Management 14.4 9.9% Ball Corp. BALL Containers/ Packaging 14.3 9.7% Source: FactSet You may need to scroll the table to see all of the data. It is a varied list. Super Micro Computer SMCI ranks second, with a 31.9% CAGR expected for sales per share through 2026. The stock soared last month after President Donald Trump announced investment agreements with Saudi Arabia to build data centers in the U.S., which lifted suppliers of related equipment. Read: Super Micro's stock keeps surging. Here's what might come next. It might surprise you to see UnitedHealth Group UNH on the list, in light of the company's numerous difficulties. These have included higher-than-expected costs in its Medicare Advantage business, reports of a government investigation into possible healthcare fraud and the departure of Chief Executive Andrew Witty. But with the stock having tumbled 40% this year through Friday, with dividends reinvested, analysts working for brokerage and research firms believe the worst is over, with 21 out of 29 analysts polled by FactSet rating UnitedHealth a buy or the equivalent. Only three of the analysts rate the stock a sell or the equivalent. Leaving the companies passing the screen in the same order, here is a summary of analysts' opinions about the stocks: Company Ticker Share buy ratings Share neutral ratings Share sell ratings May 30 price Consensus price target Implied 12-month upside potential Expand Energy Corp. EXE 90% 10% 0% $116.13 $128.45 11% Super Micro Computer Inc. SMCI 47% 41% 12% $40.02 $40.69 2% EQT Corp. EQT 72% 24% 4% $55.13 $60.63 10% Micron Technology Inc. MU 85% 12% 3% $94.46 $123.95 31% Coterra Energy Inc. CTRA 83% 17% 0% $24.31 $33.41 37% First Solar Inc. FSLR 78% 20% 2% $158.08 $202.43 28% Norwegian Cruise Line Holdings Ltd. NCLH 72% 28% 0% $17.65 $23.65 34% Incyte Corp. INCY 45% 52% 3% $65.06 $73.95 14% Seagate Technology Holdings PLC STX 59% 36% 5% $117.94 $119.88 2% Gen Digital Inc. GEN 45% 55% 0% $28.48 $31.83 12% DaVita Inc. DVA 9% 83% 8% $136.26 $167.14 23% ONEOK Inc. OKE 67% 33% 0% $80.84 $106.75 32% Molina Healthcare Inc. MOH 42% 47% 11% $305.04 $356.93 17% Aptiv PLC APTV 68% 23% 9% $66.81 $75.76 13% UnitedHealth Group Inc. UNH 73% 17% 10% $301.91 $376.05 25% Elevance Health Inc. ELV 75% 25% 0% $383.84 $491.94 28% Dell Technologies Inc. Class C DELL 81% 19% 0% $111.27 $136.52 23% American International Group Inc. AIG 55% 45% 0% $84.64 $90.88 7% HCA Healthcare Inc. HCA 59% 34% 7% $381.39 $387.95 2% Ball Corp. BALL 61% 33% 6% $53.58 $61.23 14% Source: FactSet Any stock screen has its limits and should only be used as a tool as part of your own research if you are selecting individual companies for investment. Click on the tickers for more about each company. Read: Tomi Kilgore's detailed guide to the information available on the MarketWatch quote page 'You never know what might happen': How do I make sure my son-in-law doesn't get his hands on my daughter's inheritance? Strategists forecast a sizzling summer for small-cap stocks 'I am getting very frustrated': My mother's adviser has not returned my calls. He manages $1 million. Is this normal? My life partner is 18 years my senior. He wants to leave his $4.5 million fortune to me — not his two kids. Do we tell them? 'I'm afraid to ask her': My stepmother won't show me my father's will. What now?
Miami Herald
35 minutes ago
- Miami Herald
Major healthcare business files for Chapter 11 bankruptcy
Biotechnology companies often encounter common challenges of long timelines for developing their products, the high costs associated with creating their innovations, and regulatory problems that must be solved to bring their inventions to market. Companies will amass huge amounts of debt over the years that's needed to develop medical devices, drugs, and other products, which can lead to financial distress and sometimes bankruptcy filings. Don't miss the move: Subscribe to TheStreet's free daily newsletter Over a 12-year period from 2011 through 2022, biotech firms filed fewer than 10 bankruptcies each year, but that changed beginning in 2023. Related: Key healthcare company files for Chapter 11 bankruptcy Biotech firms filed 14 cases in 2023, which was the highest number since 2010, when 14 firms filed for bankruptcy. Companies filed 13 petitions in 2024. Economic issues common to all businesses, such as rising costs of labor and products driven by inflation and rising inflation, played a role in distress over the last two years. AmplifyBio, which develops next-generation vaccines, medicine, and therapeutics, filed for Chapter 11 protection on May 17, 2025, seeking to sell all of its assets and liquidate through the bankruptcy process. The debtor's largest creditors included certain shareholders, including Battelle Services Co., owed $3.25 million; Battelle Memorial Institute, owed $1.89 million; and Kavra 14 LLC, owed $1.8 million. Distressed biotechnology company Synthego Corp. filed for Chapter 11 bankruptcy protection on May 5, seeking to sell its assets to its prepetition lender Perceptive Credit Holdings III L.P. in a bankruptcy sale with a stalking-horse bid calling for a credit bid of $74.4 million of debt owed to the lender, as well as a $12.5 million DIP financing. Austin, Texas-based biotechnology company Molecular Templates Inc., which develops cancer treatment drugs, filed for Chapter 11 bankruptcy on April 20, 2025, with plans to hand its assets to its secured lender as part of a restructuring support agreement. And now, medical diagnostics company Capture Collective Inc., which is developing and commercializing medical testing equipment for early detection of radiation exposure, and two affiliates, filed for Chapter 11 bankruptcy protection on May 27 to reorganize their debts, facing high litigation costs. Related: Major health care company files for bankruptcy to sell assets The company listed $1 million to $10 million in assets and liabilities in its petition filed in the U.S. Bankruptcy Court for the Southern District of Ohio, including a $5.7 million disputed tax claim owed to its largest creditor Hawaii Department of Taxation. More bankruptcy: Iconic auto repair chain franchise files Chapter 11 bankruptcyPopular beer brand closes down and files Chapter 7 bankruptcyPopular vodka and gin brand files for Chapter 11 bankruptcy The Columbus, Ohio-based debtor and affiliates Capture Diagnostics LLC and Capture Diagnostics HIB01 had also faced costly contract disputes as a result of its Covid-19 testing business that ceased operations in May 2023. Capture Collective was unable to resolve the contract disputes with claimants after the Covid-19 testing business ended. The company said high litigation costs had exhausted all of its remaining capital resources and made it impossible for the company to obtain new venture capital, according to information provided by RK Consultants. All litigation filed against Capture Collective and its affiliates is subject to an automatic stay while the bankruptcy case proceeds. Capture Collective is developing the radiation biodosimetry diagnostic test, MiRAD, a high-throughput, microRNA biomarker-based biodosimetry assay, which enables individualized clinical biomarker quantification in direct correlation with radiation exposure. Related: Another major healthcare company files Chapter 11 bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
36 minutes ago
- Yahoo
‘Something you can never replace': NC widows sue Myrtle Beach aviation company after husbands 2022 plane crash deaths
HORRY COUNTY, S.C. (WBTW) — Two North Carolina widows say they're heartbroken and frustrated after filing a federal lawsuit in February against a Myrtle Beach-based aviation company that may be liable for the deaths of their husbands. 'As much as we don't want to go to trial, we will do anything for justice,' widow Toni Titone said. Terry Druffel and Barrie McMurtrie died in a single-engine plane crash in a wooded area outside of Conway in September 2022. Almost six hours after the crash, widow Linda Druffel says the Horry County coroner called her and Toni Titone to tell them their husbands died at the scene. The widows told News13 the plane was in flames when it crashed. They say authorities could not identify their husbands until they found McMurtrie's logbook. 'This is the only thing I have left of my husband,' Linda said, holding the center of her necklace. 'It's his wedding ring from that crash.' The widows' wrongful death and negligence lawsuit says Druffel and McMurtrie flew McMurtrie's single-engine Piper PA-28R on September 14, 2022. The lawsuit claims Myrtle Beach-based Executive Helijet Aviation worked on that plane months earlier. Linda says experts who examined the plane told her, within about 10 minutes of the flight, oil started leaking from the engine. When Druffel and McMurtrie tried to land in a landfill area, their right wing hit a tree. Titone and Linda say their husbands were experienced pilots. McMurtrie flew for 30 years. Druffel spent 24 years in the Navy as a helicopter pilot and 25 years with his commercial pilot's license. 'My nephews, today, just got their private pilot's licenses because of Uncle Terry, who started flying with them when they were little boys,' Linda said. In its final report in December 2023, the National Transportation Safety Board said the probable cause of the crash was the mechanic's failure to install a required gasket on the vacuum pump drive pad, which led to a loss of engine power. Linda said 16 months before Druffel and McMurtrie died, another pilot crashed and died after Executive Helijet Aviation allegedly put equipment into his plane upside down. 'Three wonderful pilots, three wonderful men, were killed because of their negligence,' Linda said. Titone says Executive Helijet's insurance company initially offered her and Linda a $2 million policy. However, the insurance company eventually told the widows they would not be getting that money. Linda and Titone are suing the aviation company for more than $75,000. 'We didn't just lose our husbands,' Titone said. 'We lost a lot of financial stability, and we lost love.' 'We lost something you can never replace,' Linda added. In response to the widows' complaint, Executive Helijet Aviation denies any liability for the crash. News13 reached out to Executive Helijet's lawyer, but we have not heard back. Court records show jury selection is set for March 2, 2026. * * * Skylar Musick is a multimedia journalist at News13. Skylar is originally from Long Island, New York. She joined the News13 team in June 2024 after graduating from Villanova University in May 2024. Follow Skylar on X, formerly Twitter, Facebook, or Instagram, and read more of her work here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
